ArticleOncoTargets and therapy2019

Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-1 Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report.

Shanshan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.